The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Maev I.V.

GBOU VPO "Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet im. A.I. Evdokimova" Minzdrava Rossii

Bakulin I.G.

I.I. Mechnikov North-Western State Medical University, Sankt-Petersburg, Russia

Kurilovich S.A.

Research Institute of Therapy and Preventive Medicine — the branch of the Federal Research Centre of the Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia

Bakulina N.V.

I.I. Mechnikov North-Western State Medical University, Sankt-Petersburg, Russia

Andreev N.G.

A.I. Evdokimov State Medical Stomagtological University, Ministry of Health of the Russia, Moscow, Russia

Golubev N.N.

Polyclinic Three, Department for Presidential Affairs of the Russian Federation, Moscow, Russia

Helicobacter pylori and extragastroduodenal diseases: the proven facts and assumptions

Authors:

Maev I.V., Bakulin I.G., Kurilovich S.A., Bakulina N.V., Andreev N.G., Golubev N.N.

More about the authors

Journal: Russian Journal of Evidence-Based Gastroenterology. 2018;7(3): 45‑59

DOI: 10.17116/dokgastro2018703145

Read: 3410 times

Download PDF (RU)
Contact the author
Table of contents

HELICOBACTER PYLORI AND EXTRAGASTRODUODENAL DISEASES: THE PROVEN FACTS AND ASSUMPTIONS
HELICOBACTER PYLORI AND EXTRAGASTRODUODENAL DISEASES: THE PROVEN FACTS AND ASSUMPTIONS

To cite this article:

Maev IV, Bakulin IG, Kurilovich SA, Bakulina NV, Andreev NG, Golubev NN. Helicobacter pylori and extragastroduodenal diseases: the proven facts and assumptions. Russian Journal of Evidence-Based Gastroenterology. 2018;7(3):45‑59. (In Russ.)
https://doi.org/10.17116/dokgastro2018703145

Подписка 2026 Доказательная гастроэнтерология (Russian Journal of Evidence-Based Gastroenterology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The influence of Heli­cobacter pylori and duodenogastric reflux on the deve­lopment and treatment outcomes of hype­rplastic gastric polyps. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):5-9
Effi­cacy of alpha-glutamyl-tryptophan in the treatment of chro­nic atro­phic gastritis: case series. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):121-128
Evaluating the effi­cacy of the Kyoto classification of gastritis in diagnosing Heli­cobacter pylori infe­ction. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):29-38
Iron defi­ciency anemia in patients with hiatal hernias. Piro­gov Russian Journal of Surgery. 2024;(12-2):77-82
Iron supplements and erythropoiesis-stimulating agents in inte­nsive care of postpartum hemo­rrhage: a Bayesian network meta-analysis. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):59-67
Erythrocyte indi­ces — markers for the diagnosis of blood iron defi­ciency in donors. Russian Journal of Preventive Medi­cine. 2025;(6):88-91
Abstract:

The review highlights current data on the association of Helicobacter pylori infection with extragastroduodenal diseases. The negative and protective role of H. pylori in hematologic diseases, diseases of central nervous system, cardiovascular and respiratory systems, metabolic disorders, intestinal and skin diseases was analyzed. The potential effect of antihelicobacter therapy in this pathology is considered.

Keywords:

Helicobacter pylori
extragastroduodenal diseases
immune thrombocytopenic purpura
iron-deficiency anemia
eradication
bismuth

Authors:

Maev I.V.

GBOU VPO "Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet im. A.I. Evdokimova" Minzdrava Rossii

Bakulin I.G.

I.I. Mechnikov North-Western State Medical University, Sankt-Petersburg, Russia

Kurilovich S.A.

Research Institute of Therapy and Preventive Medicine — the branch of the Federal Research Centre of the Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia

Bakulina N.V.

I.I. Mechnikov North-Western State Medical University, Sankt-Petersburg, Russia

Andreev N.G.

A.I. Evdokimov State Medical Stomagtological University, Ministry of Health of the Russia, Moscow, Russia

Golubev N.N.

Polyclinic Three, Department for Presidential Affairs of the Russian Federation, Moscow, Russia

Close metadata

References:

  1. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. GUT. 2017;66(1):6-30.
  2. He C, Yang Z, Lu NH. Helicobacter pylori infection and diabetes: is it a myth or fact? World J Gastroenterol. 2014;20(16):4607-4617.
  3. Blecker U, Renders F, Lanciers S, Vandenplas Y. Syncope’s leadingto the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis. Eur J Pediatr. 1991;150:560-561. Accessed 11.08.18. https://link.springer.com/article/10.1007/BF02072207
  4. Dufour C, Brisigotti M, Fabretti G, Luxardo P, Mori PG, BaraÂbino A. Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr. 1993;17(2):225-227. Accessed 11.08.18
  5. Marignani M, Angeletti S, Bordi C, Malagnino F, Mancino C, DelleFave G, Annibale B. Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. Scand J Gastroenterol. 1997;32(6):617-622.
  6. Franceschi F, Zuccala G, Roccarina D, Gasbarrini A. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol. 2014;11(4):234-242.
  7. Muhsen K, Cohen D. Helicobacter pylori infection and iron stores: a systematic review and metaanalysis. Helicobacter. 2008;13:323-340. https://doi.org/10.1111/j.1523-5378.2008.00617.x
  8. Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY, Lin H, Cai MC, Chen ZW, Hu B, Wu LM, Jiang YB, Yan WL. Does Helicobacter pylori infection play a role in iron deficiency anemia? A metaanalysis. World J Gastroenterol. 2010;16(7):886-896.
  9. Hudak L, Jaraisy A, Haj S, Muhsen K. An updated systematic review and metaanalysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 2017;22(1).
  10. Yuan W, Li Yumin, Yang Kehu, Ma Bin, Guan Quanlin, Wang D, Yang L. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2010;45(6):665-676.
  11. Huang X, Qu X, Yan W, Huang Y, Cai M, Hu B, Wu L, Lin H, Chen Z, Zhu C, Lu L, Sun X, Rong L, Jiang Y, Sun D, Zhong L, Xiong P. Iron deficiency anemia can be improved after eradication of Helicobacter pylori. Postgrad Med J. 2010;86(1015):272-278.
  12. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold D.M, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from international working group. Blood. 2009;113(11):2386-2393.
  13. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352(9131):878.
  14. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009;113(6):1231-1240.
  15. Arnold DM, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y, Kelton JG, Crowther MA. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica. 2009;94(6):850-856. https://doi.org/10.3324/haematol.2008.005348
  16. Kikuchi T, Kobayashi T, Yamashita T, Ohashi K, Sakamaki H, AkiyaÂma H. Eight-year follow-up of patients with immune thrombocytopenic purpura related to H. pylori infection. Platelets. 2011;22(1):61-64. https://doi.org/10.3109/09537104.2010.515272
  17. Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography. Helicobacter. 2015;20(4):239-251. https://doi.org/10.1111/hel.12200
  18. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190-4207.
  19. National clinical guidelines for the diagnosis and treatment of idiopathic thrombocytopenic purpura (primary immune thrombocytopenia) in adults (edition 2018). (In Russ.) Accessed 05.08.18
  20. Lahner E, Persechino S, Annibale B. Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter. 2012;17(1):1-15.
  21. Franceschi F, Annalisa T, Teresa DR, Giovanna D, Ianiro G, Franco S, Viviana G, Valentina T, Riccardo LL, Antonio G. Role of Helicobacter pylori infection on nutrition and metabolism. World J Gastroenterol. 2014;20(36):12809-12817.
  22. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71(5):437-439. Accessed 05.08.18
  23. Kucukazman M, Yeniova O, Dal K, Yavuz B. Helicobacter pylori and cardiovascular disease. Eur Rev Med Pharmacol Sci. 2015;19(19):3731-3741. Accessed 05.08.18
  24. Sun J, Rangan P, Bhat SS, Liu L. A metaanalysis of the association between Helicobacter pylori infection and risk of coronary heart disease from published prospective studies. Helicobacter. 2016;21(1):11-23.
  25. Pasceri V, Patti G, Cammarota G, Pristipino C, Richichi G, Di Sciascio G. Virulent strains of Helicobacter pylori and vascular diseases: a metaanalysis. Am Heart J. 2006;151(6):1215-1222.
  26. Franceschi F, Niccoli G, Ferrante G, Gasbarrini A, Baldi A, Candelli M, Feroce F, Saulnier N, Conte M, Roccarina D, Lanza GA, Gasbarrini G, Gentiloni SN, Crea F. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a metaanalysis of 4241 cases. Atherosclerosis. 2009;202(2):535-542.
  27. Yu XJ, Yang X, Feng L, Wang LL, Dong QJ. Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: A metaanalysis. Exp Ther Med. 2017;13(2):787-793. https://doi.org/10.3892/etm.2017.4028
  28. Liu J, Wang F, Shi S. Helicobacter pylori infection increase the risk of myocardial infarction: a meta-analysis of 26 studies involving more than 20,000 participants. Helicobacter. 2015;20(3):176-183.
  29. Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol. 2001;52(Suppl 1):3-31. Accessed 05.08.18
  30. Iriz E, Cirak MY, Engin ED, Zor MH, Erer D, Ozdogan ME, Turet S, Yener A. Detection of Helicobacter pylori DNA in aortic and left internal mammary artery biopsies. Tex Heart Inst J. 2008;35(2):130-135. Accessed 05.08.18
  31. Kim H-L, Jeon HH, Park IY, Choi JM, Kang JS, Min K-W. Helicobacter pylori Infection is associated with elevated low-density lipoprotein cholesterol levels in elderly Koreans. J Korean Med Sci. 2011;26(5):654-658. https://doi.org/10.3346/jkms.2011.26.5.654
  32. Haeri M, Parham M, Habibi N, Vafaeimanesh J. Effect of Helicobacter pylori Infection on serum lipid profile. J Lipids. 2018;6734809. https://doi.org/10.1155/2018/6734809
  33. Nam SY, Ryu KH, Park BJ, Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter. 2015;20(2):125-132.
  34. Vijayvergiya R, Vadivelu R. Role of Helicobacter pylori infection in pathogenesis of atherosclerosis. World J Cardiol. 2015;7:134-143.
  35. Jamkhande PG, Gattani SG, Farhat SA. Helicobacter pylori and cardiovascular complications: a mechanism based review on role of Helicobacter pylori in cardiovascular diseases. Integr Med Res. 2016;5(4):244-249.
  36. Upala S, Jaruvongvanich V, Riangwiwat T, Jaruvongvanich S, Sanguankeo A. Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and metaanalysis. J Dig Dis. 2016;17(7):433-440.
  37. Refaeli R, Chodick G, Haj S, Goren S, Shalev V, Muhsen K. Relationships of H. pylori infection and its related gastroduodenal morbidity with metabolic syndrome: a large cross-sectional study. Sci Rep. 2018;8(1):4088.
  38. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45(8):1219-1222.
  39. Roper J, Francois F, Shue PL, Mourad MS, Pei Z, Olivares de Perez AZ, Perez-Perez GI, Tseng CH, Blaser MJ. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab. 2008;93(6):2350-2357.
  40. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J. 2010;103(3):190-196.
  41. Mokhtare M, Mirfakhraee H, Arshad M, Samadani Fard SH, Bahardoust M, Movahed A, Masoodi M. The effects of helicobacter pylori eradication on modification of metabolic syndrome parameters in patients with functional dyspepsia. Diabetes Metab Syndr. 2017;11(Suppl 2):S1031-S1035.
  42. Konturek PC, Czesnikiewicz-Guzik M, Bielanski W, Konturek SJ. Involvement of Helicobacter pylori infection in neuro-hormonal control of food intake. J Physiol Pharmacol. 2006;57(Suppl. 5):67-81. Accessed 05.08.18
  43. He C, Yang Z, Lu NH. Helicobacter pylori infection and diabetes: is it a myth or fact? World J Gastroenterol. 2014;20(16):4607-4617.
  44. Lender N, Talley NJ, Enck P, Haag S, Zipfel S, Morrison M, Holtmann GJ. Review article: Associations between Helicobacter pylori and obesity — an ecological study. Aliment Pharmacol Ther. 2014;40(1):24-31.
  45. Lee YY, Mahendra Raj S, Graham DY. Helicobacter pylori infection — a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter. 2013;18(5):338-346.
  46. Li JZ, Li JY, Wu TF, Xu JH, Huang CZ, Cheng D, Chen QK, Yu T. Helicobacter pylori infection is associated with type 2 diabetes, not type 1 diabetes: an updated metaanalysis. Gastroenterol Res Pract. 2017;2017:5715403.
  47. Wang F, Liu J, Lv Z. Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: a metaanalysis of 39 studies involving more than 20,000 participants. Scand J Infect Dis. 2013;45(12):930-938.
  48. Vafaeimanesh J, Rajabzadeh R, Ahmadi A, Moshtaghi M, Banikarim S, Hajiebrahimi S, Seyyedmajidi M. Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens. Arab J Gastroenterol. 2013;14(2):55-58.
  49. Bonfigli AR, Boemi M, Festa R, Bonazzi P, Brandoni G, Spazzafumo L, Olivieri F, Ceriello A, Genovese S, Testa R. Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2016;26(10):893-898. https://doi.org/10.1016/j.numecd.2016.06.012
  50. Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Manatsathit W, Jaruvongvanich V, Ungprasert P. Helicobacter pylori and risk of nonalcoholic fatty liver disease: a systematic review and metaanalysis. J Clin Gastroenterol. 2018;52(5):386-391.
  51. Tang DM, Kumar S. The association between Helicobacter pylori infection and nonalcoholic fatty liver disease. Curr Gastroenterol Rep. 2017;19(2):5.
  52. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259-1260. Accessed 05.08.18
  53. Okada H, Kuhn C, Feillet H, Bach JF. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin Exp Immunol. 2010;160(1):1-9.
  54. Sommer F, Faller G, Konturek P, Kirchner T, Hahn EG, Zeus J, Rollinghoff M, Lohoff M. Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun. 1998;66(11):5543-5546. Accessed 05.08.18
  55. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Muller A. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T-cells. J Clin Invest. 2011;121(8):3088-3093.
  56. Fujimura KE, Demoor T, Rauch M, Faruqi AA, Jang S, Johnson CC, Boushey HA, Zoratti E, Ownby D, Lukacs NW, Lynch SV. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci USA. 2014;111(2):805-810.
  57. Renz H, Brandtzaeg P, Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol. 2011;12(1):9-23.
  58. Miftahussurur M, Nusi IA, Graham DY, Yamaoka Y. Helicobacter, Hygiene, atopy, and asthma. Front Microbiol. 2017;8:1034.
  59. Zhou X, Wu J, Zhang G. Association between Helicobacter pylori and asthma: a metaanalysis. Eur J Gastroenterol Hepatol. 2013;25(4):460-468.
  60. Chen C, Xun P, Tsinovoi C, He K. Accumulated evidence on Helicobacter pylori infection and the risk of asthma: A metaanalysis. Ann Allergy Asthma Immunol. 2017;119(2):137-145.e2.
  61. Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015;148(4):719-731. https://doi.org/10.1053/j.gastro.2015.01.040
  62. Vercelli D. Mechanisms of the hygiene hypothesis — molecular and otherwise. Curr Opin Immunol. 2006;18(6):733-737.
  63. Campbell B, Raherison C, Lodge CJ, Lowe AJ, Gislason T, Heinrich J, Sunyer J, Gomez Real F, Norback D, Matheson MC, Wjst M, Dratva J, de Marco R, Jarvis D, Schlunssen V, Janson C, Leynaert B, Svanes C, Dharmage SC. The effects of growing up on a farm on adult lung function and allergic phenotypes: an international population-based study. Thorax. 2017;72(3):236-244.
  64. Kyburz A, Muller A. Helicobacter pylori and Extragastric Diseases. Curr Top Microbiol Immunol. 2017;400:325-347.
  65. Alvarez-Arellano L, Maldonado-Bernal C. Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol. 2014;5(4):400-404.
  66. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke. 2001;32(2):385-391. Accessed 05.08.18
  67. Wang ZW, Li Y, Huang LY, Guan QK, Xu DW, Zhou WK, Zhang XZ. Helicobacter pylori infection contributes to high risk of ischemic stroke: evidence from a meta-analysis. J Neurol. 2012;259(12):2527-2537.
  68. Sochocka M, Zwolińska K, Leszek J. The infectious etiology of Alzheimer’s disease. Curr Neuropharmacol. 2017;15(7):996-1009.
  69. Deretzi G, Kountouras J, Polyzos SA, Zavos C, Giartza-Taxidou E, Gavalas E, Tsiptsios. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases. Curr Mol Med. 2011;11(8):696-707.
  70. Doulberis M, Kotronis G, Thomann R, Polyzos SA, Boziki M, Gialamprinou D, Deretzi G, Katsinelos P, Kountouras J. Review: impact of Helicobacter pylori on Alzheimer’s disease: What do we know so far? Helicobacter. 2018;23(1).
  71. Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology. 2006;66(6):938-940.
  72. Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G, Tzilves D, Katsinelos P, Tsolaki M, Chatzopoulos D, Venizelos I. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease. J Neurol. 2009;256(5):758-767. https://doi.org/10.1007/s00415-009-5011-z
  73. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Chatzigeorgiou S, Katsinelos P, Grigoriadis N, Giartza-Taxidou E, Venizelos I. Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol. 2010;23(3):199-204. https://doi.org/10.1097/WNN.0b013e3181df3034
  74. Shiota S, Murakami K, Yoshiiwa A, Yamamoto K, Ohno S, Kuroda A, Mizukami K, Hanada K, Okimoto T, Kodama M, Abe K, Yamaoka Y, Fujioka T. The relationship between Helicobacter pylori infection and Alzheimer’s disease in Japan. J Neurol. 2011;258(8):1460-1463.
  75. Shindler-Itskovitch T, Ravona-Springer R, Leibovitz A, Muhsen K. A systematic review and meta-analysis of the association between Helicobacter pylori infection and dementia. J Alzheimers Dis. 2016;52(4):1431-1442.
  76. Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896-912. https://doi.org/10.1016/S0140-6736(14)61393-3
  77. Bu XL, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, Jiao SS, Wang YR, Cao HY, Yi X, Liu CH, Deng B, Yao XQ, Xu ZQ, Zhou HD, Wang YJ. The association between infectious burden and Parkinson’s disease: A case-control study. Parkinsonism Relat Disord. 2015;21(8):877-881.
  78. Camcı G, Oguzb S. Association between Parkinson’s disease and Helicobacter pylori. J Clin Neurol. 2016;12(2):147-150.
  79. Deretzi G, Kountouras J, Polyzos SA, Zavos C, Giartza-Taxidou E, Gavalas E, Tsiptsios I. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases. Curr Mol Med. 2011;11(8):696-707.
  80. Kountouras J, Zavos C, Polyzos SA, Deretzi G, Vardaka E, Giartza-Taxidou E, Katsinelos P, Rapti E, Chatzopoulos D, Tzilves D, Stergiopoulos C, Christodoulou K. Helicobacter pylori infection and Parkinson’s disease: apoptosis as an underlying common contributor. Eur J Neurol. 2012;19(6):e56.
  81. Shen X, Yang H, Wu Y, Zhang D, Jiang H. Meta-analysis: Association of Helicobacter pylori infection with Parkinson’s diseases. Helicobacter. 2017;22(5).
  82. Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MR, Ibrahim NM. Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson’s disease. PLoS One. 2014;9(11):e112330.
  83. Lahner E, Annibale B, Delle Fave G. Systematic review: HelicoÂbacter pylori infection and impaired drug absorption. Aliment Pharmacol Ther. 2009;29(4):379-386.
  84. Grigoriadis N, van Pesch V, ParadigMS Group. A basic overview of multiple sclerosis immunopathology. Eur J Neurol: Off J Eur Fed Neurol Soc. 2015;22(Suppl 2):(2):3-13.
  85. Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev. 2010;9(5):A387-A394.
  86. Jaruvongvanich V, Sanguankeo A, Jaruvongvanich S, Upala S. Association between Helicobacter pylori infection and multiple sclerosis: a systematic review and metaanalysis. Mult Scler Relat Disord. 2016;7:92-97.
  87. Yao G, Wang P, Luo XD, Yu TM, Harris RA, Zhang XM. Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis. Neurosci Lett. 2016;620:1-7.
  88. Schwedt TJ. Chronic migraine. BMJ. 2014;348:g1416.
  89. Camara-Lemarroy CR, Rodriguez-Gutierrez R, Monreal-Robles R, Marfil-Rivera A. Gastrointestinal disorders associated with migraine: a comprehensive review. World J Gastroenterol. 2016;22(36):8149-8160. https://doi.org/10.3748/wjg.v22.i36.8149
  90. Doulberis M, Saleh C, Beyenburg S. Is there an association between migraine and gastrointestinal disorders? J Clin Neurol. 2017;13(3):215-226.
  91. Su J, Zhou XY, Zhang GX. Association between Helicobacter pylori infection and migraine: a metaanalysis. World J Gastroenterol. 2014;20(40):14965-14972.
  92. Gasbarrini A, De Luca A, Fiore G, Franceschi F, Ojetti VV, Torre ES, Di Campli C, Candelli M, Pola R, Serricchio M, Tondi P, Gasbarrini G, Pola P, Giacovazzo M. Primary headache and Helicobacter pylori. Int J Angiol. 1998;7(4):310-312.
  93. Tunca A, Turkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A case-control study. Acta Neurol Belg. 2004;104(4):161-164. Accessed 11.08.18
  94. Faraji F, Zarinfar N, Zanjani AT, Morteza A. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. Pain Physician. 2012;15(6):495-498. Accessed 11.08.18
  95. Zhang Y, Hoffmeister M, Weck MN, Chang-Claude J, Brenner H. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol. 2012;175(5):441-450.
  96. Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol. 2013;108(2):208-215.
  97. Wu Q, Yang ZP, Xu P, Gao LC, Fan DM. Association between Helicobacter pylori infection and the risk of colorectal neoplasia: a systematic review and metaanalysis. Colorectal Dis. 2013;15(7):e352-e364. https://doi.org/10.1111/codi.12284
  98. Wang F, Sun MY, Shi SL, Lv ZS. Helicobacter pylori infection and normal colorectal mucosa-adenomatous polyp-adenocarcinoma sequence: a metaanalysis of 27 case-control studies. Colorectal Dis. 2014;16(4):246-252.
  99. Yan Y, Chen YN, Zhao Q, Chen C, Lin CJ, Jin Y, Pan S, Wu JS. Helicobacter pylori infection with intestinal metaplasia: An independent risk factor for colorectal adenomas. World J Gastroenterol. 2017;23(8):1443-1449. https://doi.org/10.3748/wjg.v23.i8.1443
  100. Inoue I, Kato J, Tamai H, Iguchi M, Maekita T, Yoshimura N, Ichinose M. Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms. World J Gastroenterol. 2014;20(6):1485-1492.
  101. Arnold IC, Muller A. Helicobacter pylori: does gastritis prevent colitis? Inflamm Intest Dis. 2016;1(3):102-112.
  102. Castano-Rodriguez N, Kaakoush NO, Lee WS, Mitchell HM. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and metaanalysis. Gut. 2017;66(2):235-249.
  103. Lebwohl B, Blaser MJ, Ludvigsson JF, Green PH, Rundle A, Sonnenberg A, Genta RM. Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol. 2013;178(12):1721-1730.
  104. Narang M, Puri AS, Sachdeva S, Singh J, Kumar A, Saran RK. Celiac disease and Helicobacter pylori infection in children: is there any association? J Gastroenterol Hepatol. 2017;32(6):1178-1182.
  105. Lucero Y, Oyarzún A, O’Ryan M, Quera R, Espinosa N, Valenzuela R, Simian D, Alcalde E, Arce C, Farfán MJ, Vergara AF, Gajardo I, Mendez J, Carrasco J, Errazuriz G, Gonzalez M, Ossa JC, Maiza E, Perez-Bravo F, Castro M, Araya M. Helicobacter pylori cagA+ is associated with milder duodenal histological changes in Chilean celiac patients. Front Cell Infect Microbiol. 2017;7:376.
  106. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B, Maurer M; Dermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64(10):1417-1426.
  107. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol. 2003;49(5):861-864.
  108. Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation system. Curr Opin Allergy Clin Immunol. 2010;10(4):362-369.
  109. Gu H, Li L, Gu M, Zhang G. Association between Helicobacter pylori infection and chronic urticaria: a metaanalysis. Gastroenterol Res Pract. 2015;2015:486974.
  110. Pawlowicz R, Wytrychowski K, Panaszek B. Eradication of Helicobacter pylori, as add-on therapy, has a significant, but temporary influence on recovery in chronic idiopathic urticaria: a placebo-controlled, double blind trial in the Polish population. Postepy Dermatol Alergol. 2018;35(2):151-155.
  111. Magen E, Mishal J. Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria. Clin Exp Dermatol. 2013;38(1):7-12.
  112. Lazaridou E, Korfitis C, Kemanetzi C, Sotiriou E, Apalla Z, Vakirlis E, Fotiadou C, Lallas A, Ioannides D. Rosacea and Helicobacter pylori: links and risks. Clin Cosmet Investig Dermatol. 2017;10:305-310.
  113. Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci. 2009;55(2):77-81.
  114. Mashimo M, Nishikawa M, Higuchi K, Hirose M, Wei Q, Haque A, Sasaki E, Shiba M, Tominaga K, Watanabe T, Fujiwara Y, Arakawa T, Inoue M. Production of reactive oxygen species in peripheral blood is increased in individuals with Helicobacter pylori infection and decreased after its eradication. Helicobacter. 2006;11(4):266-271. https://doi.org/10.1111/j.1523-5378.2006.00410.x
  115. Jorgensen AR, Egeberg A, Gideonsson R, Weinstock LB, Thyssen EP, Thyssen JP. Rosacea is associated with Helicobacter pylori: a systematic review and metaanalysis. J Eur Acad Dermatol Venereol. 2017;31(12):2010-2015.
  116. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut. 2000;46 (Suppl 3-4):IV1-IV5.
  117. Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AFG. Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects. World J Gastroenterol. 2018;24(28):3071-3089. https://doi.org/10.3748/wjg.v24.i28.3071
  118. Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: a review. World J Gastroenterol. 2018;24(29):3204-3221.
  119. Wuppenhorst N, Draeger S, Stuger HP, Hobmaier B, Vorreiter J, Kist M, Glocker EO; ResiNet Study Group. Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany. Antimicrob Chemother. 2014;69(11):3127-3133.
  120. Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014;12(2):177-186.
  121. Dore MP, Lu H, Graham DY. Role of bismuth in improving Helicobacter pylori eradication with triple therapy. Gut. 2016;65(5):870-878. https://doi.org/10.1136/gutjnl-2015-311019
  122. Gisbert JP, McNicholl AG. Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies. Helicobacter. 2017;e12392.
  123. Ivashkin VT, Mayev IV, Lapina TL, Sheptulin AA, Trukhmanov AS, Baranskaya YeK, Abdulkhakov RA, Alekseyeva OP, Alekseyenko SA, Dekhnich NN, Kozlov RS, Klyaritskaya IL, Korochanskaya NV, Kurilovich SA, Osipenko MF, Simanenkov VI, Tkachev AV, Khlynov IB, Tsukanov VV. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association. Ross Z gastroenterol gepatol koloproktol. 2018;28(1):55-70. (In Russ.)
  124. Lazebnik LB, Tkachenko EI, Abdulganiyeva DI, Abdulkhakov RA, Abdulkhakov SR, Avaluyeva EB, Ardatskaya MD, Akhmedov VA, Bordin DS, Burkov SG, Butov MA, Golovanova EV, Golofeyevskiy VYu, Grinevich VB, Dzhulay GS, Dobritsa VP, Eremina EYu, Zhigalova TN, Ivanikov IO, Isakov VA, Kazyulin AN, Kalinin AV, Kozlova IV, Komissarenko IA, Kornienko EA, Korochanskaya NV, Kurilovich SA, Kucheryavyy YuA, Li ED, Li IA, Levchenko SV., Livzan MA, Loginov AF, Loranskaya ID, Mayev IV, Maksimov VA, Miller DA, Minushkin ON, Nizov AA, Oreshko LS, Osipenko MF, Paltsev AI, Pasechnikov VD, Radchenko VG, Rustamov MN, Sablin OA, Sagynbayeva VE, Sayfutdinov RG, Samsonov AA, Sarsenbayeva AS, Seliverstov PV, Simanenkov VI, Sitkin SI, Starostin BD, Suvorov AN, Tarasova LV, Tkachev AV, Uspenskiy YuP, Khlynova OV, Khomeriki NM, Khomeriki SG, Tsukanov VV, Chernin VV, Chernyshev AL, Sharkhun OO, Scherbakov PL, Yakovenko EP. VI National guidelines for the diagnosis and treatment of acid-related and Helicobacter pylori-associated diseases (VI Moscow agreement). Exp Clin Gastroenterol. 2017;2(138):3-21. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.